SCIENTURE HOLDINGS, INC. (SCNX) Scorecard
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Win.
44/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 2 wins, 10 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinSCNX / S&P 22.81% / 15.20% |
LoseSCNX / S&P SCNX unavailable / 15.00% |
LoseSCNX / S&P -74.58% / 50.40% |
| 2026-Q10/3 |
LoseSCNX / S&P -44.12% / -4.33% |
LoseSCNX / S&P SCNX unavailable / 11.30% |
LoseSCNX / S&P -72.36% / 27.70% |
| 2025-Q40/3 |
LoseSCNX / S&P -40.00% / 2.65% |
LoseSCNX / S&P SCNX unavailable / 9.00% |
LoseSCNX / S&P -134.41% / 13.40% |
| 2025-Q31/3 |
LoseSCNX / S&P -18.27% / 8.12% |
LoseSCNX / S&P SCNX unavailable / 4.61% |
WinSCNX / S&P 1322.00% / 13.45% |
| 2025-Q21/3 |
LoseSCNX / S&P -27.78% / 10.94% |
LoseSCNX / S&P SCNX unavailable / 4.83% |
WinSCNX / S&P 121.45% / 10.63% |
| 2025-Q11/3 |
LoseSCNX / S&P -76.20% / -4.27% |
LoseSCNX / S&P SCNX unavailable / 4.98% |
WinSCNX / S&P 70.36% / 10.57% |
| 2024-Q40/3 |
LoseSCNX / S&P -20.18% / 2.41% |
LoseSCNX / S&P SCNX unavailable / 5.25% |
LoseSCNX / S&P -134.70% / 6.15% |
| 2024-Q30/3 |
LoseSCNX / S&P -27.27% / 5.89% |
LoseSCNX / S&P SCNX unavailable / 5.89% |
LoseSCNX / S&P -94.98% / 6.11% |
| 2024-Q21/3 |
WinSCNX / S&P 9.08% / 4.28% |
LoseSCNX / S&P SCNX unavailable / 5.38% |
LoseSCNX / S&P -40.89% / 5.12% |
| 2024-Q11/3 |
WinSCNX / S&P 195.18% / 10.56% |
LoseSCNX / S&P SCNX unavailable / 5.71% |
LoseSCNX / S&P -1.30% / 5.59% |
| 2023-Q41/3 |
LoseSCNX / S&P -26.09% / 11.69% |
LoseSCNX / S&P -87.25% / 6.81% |
WinSCNX / S&P 412.42% / 7.78% |
| 2023-Q31/3 |
LoseSCNX / S&P -46.13% / -3.27% |
LoseSCNX / S&P -68.00% / 7.52% |
WinSCNX / S&P 220.58% / -5.03% |
| 2023-Q22/3 |
WinSCNX / S&P 194.92% / 8.74% |
LoseSCNX / S&P -54.86% / 9.50% |
WinSCNX / S&P 167.37% / -8.57% |
| 2023-Q11/3 |
LoseSCNX / S&P -26.80% / 7.50% |
LoseSCNX / S&P -19.77% / 10.77% |
WinSCNX / S&P 682.61% / -15.69% |
| 2022-Q41/3 |
LoseSCNX / S&P -64.34% / 7.56% |
LoseSCNX / S&P 9.52% / 11.88% |
WinSCNX / S&P 593.85% / -17.99% |
| 2022-Q31/3 |
LoseSCNX / S&P -30.25% / -4.88% |
WinSCNX / S&P 15.45% / 13.47% |
LoseSCNX / S&P SCNX unavailable / -1.41% |
| 2022-Q20/3 |
LoseSCNX / S&P -41.52% / -16.10% |
LoseSCNX / S&P -13.72% / 13.71% |
LoseSCNX / S&P SCNX unavailable / 11.04% |
| 2022-Q11/3 |
WinSCNX / S&P 17.37% / -4.60% |
LoseSCNX / S&P -43.93% / 15.97% |
LoseSCNX / S&P SCNX unavailable / 42.23% |
| 2021-Q40/3 |
LoseSCNX / S&P -52.07% / 11.03% |
LoseSCNX / S&P -42.24% / 15.00% |
LoseSCNX / S&P SCNX unavailable / 96.40% |
| 2021-Q31/3 |
WinSCNX / S&P 11.40% / 0.58% |
LoseSCNX / S&P -43.56% / 10.77% |
LoseSCNX / S&P SCNX unavailable / 69.42% |
| 2021-Q20/3 |
LoseSCNX / S&P -15.65% / 8.55% |
LoseSCNX / S&P 3.71% / 6.58% |
LoseSCNX / S&P SCNX unavailable / 51.81% |
| 2021-Q11/3 |
LoseSCNX / S&P -0.95% / 6.17% |
WinSCNX / S&P 121.14% / -1.06% |
LoseSCNX / S&P SCNX unavailable / 7.39% |
| 2020-Q41/3 |
LoseSCNX / S&P -15.36% / 12.15% |
WinSCNX / S&P 130.26% / -3.72% |
LoseSCNX / S&P SCNX unavailable / -33.42% |
| 2020-Q31/3 |
LoseSCNX / S&P 4.17% / 8.93% |
WinSCNX / S&P 139.18% / -2.04% |
LoseSCNX / S&P -650.00% / -27.10% |
| 2020-Q21/3 |
LoseSCNX / S&P 4.35% / 20.54% |
WinSCNX / S&P 129.86% / -0.46% |
LoseSCNX / S&P -750.00% / -27.11% |
| 2020-Q12/3 |
WinSCNX / S&P -12.88% / -19.60% |
WinSCNX / S&P 80.95% / 3.47% |
LoseSCNX / S&P -600.00% / -14.75% |
| 2019-Q42/3 |
LoseSCNX / S&P -16.67% / 9.07% |
WinSCNX / S&P 94.07% / 5.36% |
WinSCNX / S&P 400.00% / 2.99% |
| 2019-Q33/3 |
WinSCNX / S&P 140.00% / 1.70% |
WinSCNX / S&P 111.37% / 5.02% |
WinSCNX / S&P 100.00% / 0.21% |
| 2019-Q23/3 |
WinSCNX / S&P 17.02% / 4.30% |
WinSCNX / S&P 73.19% / 6.64% |
WinSCNX / S&P 100.00% / 8.65% |
| 2019-Q12/3 |
WinSCNX / S&P 56.67% / 13.65% |
WinSCNX / S&P 45.67% / 8.12% |
LoseSCNX / S&P 0.00% / 14.29% |
| 2018-Q41/3 |
LoseSCNX / S&P -40.00% / -13.52% |
WinSCNX / S&P 28.74% / 9.05% |
LoseSCNX / S&P -200.00% / 18.23% |
| 2018-Q31/3 |
LoseSCNX / S&P 0.00% / 7.71% |
WinSCNX / S&P 17.82% / 10.21% |
LoseSCNX / S&P -150.00% / 19.06% |
| 2018-Q21/3 |
LoseSCNX / S&P 0.00% / 3.43% |
WinSCNX / S&P 19.14% / 9.03% |
LoseSCNX / S&P -120.00% / 14.46% |
| 2018-Q12/3 |
WinSCNX / S&P 11.11% / -0.76% |
WinSCNX / S&P 19.35% / 7.68% |
LoseSCNX / S&P -111.11% / 12.46% |
| 2017-Q42/3 |
WinSCNX / S&P 9.76% / 6.64% |
WinSCNX / S&P 19.92% / 7.03% |
LoseSCNX / S&P -110.00% / 13.82% |
| 2017-Q31/3 |
LoseSCNX / S&P -25.45% / 4.48% |
WinSCNX / S&P 125.04% / 5.68% |
LoseSCNX / S&P -80.00% / 17.57% |
| 2017-Q21/3 |
LoseSCNX / S&P -26.67% / 3.09% |
WinSCNX / S&P 18.29% / 4.83% |
LoseSCNX / S&P -28.57% / 17.74% |
| 2017-Q12/3 |
WinSCNX / S&P 63.04% / 6.07% |
LoseSCNX / S&P -9.70% / 3.67% |
WinSCNX / S&P 200.00% / 13.32% |
| 2016-Q41/3 |
LoseSCNX / S&P -17.86% / 3.82% |
LoseSCNX / S&P -14.79% / 2.09% |
WinSCNX / S&P 233.33% / 7.05% |
| 2016-Q31/3 |
LoseSCNX / S&P -40.30% / 3.85% |
LoseSCNX / S&P -69.33% / 0.20% |
WinSCNX / S&P 233.33% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | SCNX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -61.03% | 20.78% |
| Annualized return | -61.03% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | SCNX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.21% | 83.14% |
| Annualized return | -62.01% | 12.86% |
10Y · 2016-09-01 to 2026-08-27
| Metric | SCNX total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -99.07% | 319.30% |
| Annualized return | -37.37% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |